Birzeit Pharmaceuticals Company's latest marketcap:
As of 07/05/2025, Birzeit Pharmaceuticals Company's market capitalization has reached $145.34 M. According to our data, Birzeit Pharmaceuticals Company is the 22199th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 145.34 M |
| Revenue (ttm) | 41.79 M |
| Net Income (ttm) | 7.96 M |
| Shares Out | 38.76 M |
| EPS (ttm) | 0.21 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 04/23/2025 |
| Earnings Date | 08/13/2025 |
Birzeit Pharmaceuticals Company's yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 07/05/2025 | د.أ145.34 M | -13.85% | 22199 |
| 12/31/2024 | د.أ119.62 M | -0.56% | 20047 |
| 12/31/2023 | د.أ120.29 M | -0.88% | 19802 |
| 12/29/2022 | د.أ121.36 M | 56.39% | 18965 |
| 12/28/2021 | د.أ77.6 M | 6.66% | 22558 |
| 12/31/2020 | د.أ72.75 M | 1.34% | 20452 |
| 12/31/2019 | د.أ71.79 M | 3.59% | 18067 |
| 12/16/2018 | د.أ69.3 M | -2.23% | 17398 |
| 12/31/2017 | د.أ70.88 M | 12.64% | 18008 |
| 12/29/2016 | د.أ62.92 M | 37.05% | 16462 |
Company Profile
About Birzeit Pharmaceuticals Company
Birzeit Pharmaceuticals Company is a leading manufacturer and trader of medicines in the Palestinian Authority. Established in 1973 and headquartered in Ramallah, the company serves a diverse range of healthcare needs with its extensive product portfolio.
Product Offerings
The company provides medicines across multiple therapeutic fields, including:
- Alimentary system
- Cardio-vascular system
- Muscolo-skeletal system
- Endocrines
- Central nervous system
- Genito-urinary system
- Obstetrics and gynecology
- Infections
- Dermatological preparations
- Ophthalmic drugs
- Respiratory system
- Nutrition and metabolism
- Ear, nose, and oropharynx
Over-the-Counter (OTC) Products
Birzeit Pharmaceuticals also offers a variety of OTC products, such as:
- Multivitamins and minerals
- Supplements
- Skin/topical care products
- Allergy and cold remedies
- Eye care solutions
- Mouth and nose care products
- Pain and fever medications
- Digestion and gastrointestinal aids
Dosage Forms
The company's products are available in multiple dosage forms to cater to different needs:
- Ampoules
- Capsules
- Tablets and caplets
- Syrups
- Suspensions and granules
- Ophthalmic solutions
- Semi-solids
- Powder vials
- Suppositories
- Powders
Additional Services
Beyond pharmaceuticals, Birzeit Pharmaceuticals engages in:
- Manufacturing and trading of cosmetics products
- Printing and publishing services
Market Reach
The company serves a broad clientele, including:
- The Ministry of Health
- Healthcare organizations and programs
- End users via pharmacies and physicians
Additionally, Birzeit Pharmaceuticals exports its products to international markets, primarily Algeria and Eastern Europe.
Frequently Asked Questions
-
What is Birzeit Pharmaceuticals Company's (PEX-BPC) current market cap?As of 07/05/2025, Birzeit Pharmaceuticals Company (including the parent company, if applicable) has an estimated market capitalization of $145.34 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Birzeit Pharmaceuticals Company (PEX-BPC) rank globally by market cap?Birzeit Pharmaceuticals Company global market capitalization ranking is approximately 22199 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.